Skip to Content

Theryttrex

Active Substance: yttrium [90Y] chloride
Common Name: yttrium [90Y] chloride
ATC Code: V09
Marketing Authorisation Holder: MDS Nordion S.A.
Active Substance: yttrium [90Y] chloride
Status: Withdrawn
Authorisation Date: 2003-01-07
Therapeutic Area: Radionuclide Imaging
Pharmacotherapeutic Group: Diagnostic radiopharmaceuticals

Therapeutic Indication

To be used only for the radiolabelling of carrier molecules which have been specifically developed and authorised for radiolabelling with this radionuclide.
Radiopharmaceutical precursor - Not intended for direct application to patients.

The marketing authorisation for Theryttrex has been withdrawn at the request of the marketing authorisation holder

Source: European Medicines Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide